NDC 31722-597

Ritonavir

Ritonavir

Ritonavir is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is Ritonavir.

Product ID31722-597_db633374-6d8e-4622-9fe1-f9d68baa59bb
NDC31722-597
Product TypeHuman Prescription Drug
Proprietary NameRitonavir
Generic NameRitonavir
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2018-09-17
Marketing CategoryANDA / ANDA
Application NumberANDA204587
Labeler NameCamber Pharmaceuticals, Inc.
Substance NameRITONAVIR
Active Ingredient Strength100 mg/1
Pharm ClassesHIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],UDP Glucuronosyltransferases Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 31722-597-12

120 TABLET in 1 BOTTLE (31722-597-12)
Marketing Start Date2018-09-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 31722-597-30 [31722059730]

Ritonavir TABLET
Marketing CategoryANDA
Application NumberANDA204587
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-09-17

NDC 31722-597-12 [31722059712]

Ritonavir TABLET
Marketing CategoryANDA
Application NumberANDA204587
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-09-17

Drug Details

Active Ingredients

IngredientStrength
RITONAVIR100 mg/1

OpenFDA Data

SPL SET ID:db633374-6d8e-4622-9fe1-f9d68baa59bb
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 900575
  • UPC Code
  • 0331722597128
  • 0331722597302
  • Pharmacological Class

    • HIV Protease Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitor [EPC]
    • Protease Inhibitor [EPC]
    • Cytochrome P450 3A Inhibitors [MoA]
    • Cytochrome P450 2D6 Inhibitors [MoA]
    • Cytochrome P450 2C19 Inducers [MoA]
    • Cytochrome P450 3A Inducers [MoA]
    • P-Glycoprotein Inhibitors [MoA]
    • Breast Cancer Resistance Protein Inhibitors [MoA]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 1A2 Inducers [MoA]
    • Cytochrome P450 2C9 Inducers [MoA]
    • Cytochrome P450 2B6 Inducers [MoA]
    • UDP Glucuronosyltransferases Inducers [MoA]
    • HIV Protease Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitor [EPC]
    • Protease Inhibitor [EPC]
    • Cytochrome P450 3A Inhibitors [MoA]
    • Cytochrome P450 2D6 Inhibitors [MoA]
    • Cytochrome P450 2C19 Inducers [MoA]
    • Cytochrome P450 3A Inducers [MoA]
    • P-Glycoprotein Inhibitors [MoA]
    • Breast Cancer Resistance Protein Inhibitors [MoA]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 1A2 Inducers [MoA]
    • Cytochrome P450 2C9 Inducers [MoA]
    • Cytochrome P450 2B6 Inducers [MoA]
    • UDP Glucuronosyltransferases Inducers [MoA]

    Medicade Reported Pricing

    31722059730 RITONAVIR 100 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Ritonavir" or generic name "Ritonavir"

    NDCBrand NameGeneric Name
    0054-0407RitonavirRitonavir
    31722-597RitonavirRitonavir
    60687-364RitonavirRitonavir
    60687-420RitonavirRitonavir
    65162-061RitonavirRitonavir
    65862-687RitonavirRitonavir
    68382-696RitonavirRitonavir
    70518-1086RitonavirRitonavir
    70518-1519RitonavirRitonavir
    70518-2007RitonavirRitonavir
    0074-1940NorvirRitonavir
    0074-2340NorvirRitonavir
    0074-3333NorvirRitonavir
    0074-3399NorvirRitonavir
    50090-1162NorvirRitonavir
    53808-1119NorvirRitonavir

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.